Viatris (VTRS) Shares Outstanding (Entity) (2019 - 2026)
Powered by 
Analysis
Viatris (VTRS) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.58 Bn | 38.93 Bn | 2.15 Bn | 1.17 Bn |
| 2 | Viatris | 19.17 Bn | 18.28 Bn | 1.46 Bn | 1.15 Bn |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.34 Bn | 334.51 Mn | 319.35 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 526.37 Mn | 2.10 Bn | 373.90 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 23.85 Mn |
| 8 | Amphastar Pharmaceuticals | 995.08 Mn | 704.96 Mn | 93.47 Mn | 42.53 Mn |
| 9 | Fennec Pharmaceuticals | 408.84 Mn | 367.59 Mn | 17.15 Mn | 35.03 Mn |
| 10 | RedHill Biopharma | 180.35 Mn | 180.35 Mn | - | 14.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.15 Bn |
| Mar 31, 2026 | 1.16 Bn |
| Dec 31, 2025 | 1.15 Bn |
| Sep 30, 2025 | 1.15 Bn |
| Jun 30, 2025 | 1.17 Bn |
| Mar 31, 2025 | 1.17 Bn |
| Dec 31, 2024 | 1.19 Bn |
| Sep 30, 2024 | 1.19 Bn |
| Jun 30, 2024 | 1.19 Bn |
| Mar 31, 2024 | 1.19 Bn |
| Dec 31, 2023 | 1.19 Bn |
| Sep 30, 2023 | 1.20 Bn |
| Jun 30, 2023 | 1.20 Bn |
| Mar 31, 2023 | 1.20 Bn |
| Dec 31, 2022 | 1.20 Bn |
| Sep 30, 2022 | 1.21 Bn |
| Jun 30, 2022 | 1.21 Bn |
| Mar 31, 2022 | 1.21 Bn |
| Dec 31, 2021 | 1.21 Bn |
| Sep 30, 2021 | 1.21 Bn |